Sarepta Therapeutics Awarded 25 Scholarships

The company supported students living with Duchenne muscular dystrophy and their siblings for the upcoming academic year.

Updated on Oct. 8, 2026 in Scholarships

Bold vector illustration of a graduation cap sitting on a stack of books, symbolizing academic success and scholarship support.
Sarepta Therapeutics awarded scholarships to 25 students with Duchenne muscular dystrophy and their siblings for the 2026-2027 academic year to support their college education. AI Illustration. Upload story photo >

Live Poll

Do you believe corporate-sponsored scholarship programs effectively support educational equity?

Sarepta Therapeutics has selected 25 scholarship recipients for the 2026-2027 academic year. The awards support individuals living with Duchenne muscular dystrophy and their siblings as they pursue postsecondary education.

Why it matters

The program helps reduce the financial burden of higher education for students navigating the challenges of Duchenne muscular dystrophy. By including siblings, the initiative recognizes the impact of the condition on the broader family unit.

Each of the 25 students receives a scholarship of up to $5,000 to assist with academic costs. This includes 20 individuals living with Duchenne and five siblings of those affected.

The players

Sarepta Therapeutics

Based in Cambridge, this biopharmaceutical company specializes in genetic medicine and the treatment of rare diseases.

The details

An independent committee evaluates applicants based on academic records, community involvement, essays, and letters of recommendation. To ensure fairness, all application submissions are de-identified for the selection panel.

Timeline

  1. The scholarship program was expanded in 2022 to include siblings of those with Duchenne.

  2. These scholarship awards are designated for the 2026-2027 academic year.

Culture Shift

This program reflects a growing corporate focus on supporting the long-term educational goals of patients and families within the rare disease community. It highlights a shift toward holistic patient support that extends beyond clinical treatments.

Students and families in the Cambridge area can use these funds to offset tuition and related expenses for the upcoming academic cycle. The financial support provides a tangible path to reducing the debt burden for qualified applicants managing rare disease diagnoses.

The takeaway

Maintaining a strong record of academic achievement and community involvement remains the primary path for applicants to secure these education funds. Families should monitor annual application windows to ensure they capitalize on these specialized support opportunities.

Further reading

Learn more about local educational funding opportunities on our Scholarships page.

More information

Review the full eligibility criteria on the Duchenne scholarship program information page.

Source note: This article includes information reported by La Opinión Digital.

Live Poll

Do you believe corporate-sponsored scholarship programs effectively support educational equity?